EUVIMEDEUVIMED entdecken
Open Access

Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study

Weiqi Zeng iD, Feng Zhou iD, Hai Zhao, Yukai Wang, Jingjuan Chen, Jiancong Lu, Dezhi Zheng, Jingyun Kuang, Dahua Yuan, Jing Zhou, Changzheng Shi iD, Xihai Zhao iD und 3 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.035651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Weiqi Zeng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology The First People's Hospital of Foshan Foshan Guangdong China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, PCSK9 Inhibitors, Intracranial Arteriosclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intracranial atherosclerotic stenosis is a leading cause of ischemic stroke and recurrent events due to plaque instability. High‐resolution magnetic resonance imaging identifies plaque enhancement as a key marker of instability. This study evaluated the efficacy of combined high‐intensity statins and proprotein convertase subtilisin/kexin type 9 inhibitors in plaque stabilization.

Methods

In this prospective, single‐arm study, patients with acute stroke and intracranial atherosclerotic stroke in the M1 segment of the middle cerebral artery or basilar artery were enrolled. After 24 weeks of intensive statin and evolocumab therapy, high‐resolution magnetic resonance imaging assessments of intracranial vessels were conducted at baseline and follow‐up. The primary end point was the change in stenosis degree; secondary end points included changes in plaque enhancement (contrast ratio) and plaque burden.

Results

Thirty‐six patients (median age, 58 years) participated. After therapy, stenosis decreased from 75.9% (interquartile range, 69.5%–84.8%) to 65.3% (interquartile range, 53.8%–75.0%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticHydroxymethylglutaryl-CoA Reductase InhibitorsPCSK9 InhibitorsIntracranial ArteriosclerosisAntibodies, Monoclonal, HumanizedMiddle Cerebral ArteryIschemic StrokeHumansMaleFemaleMiddle AgedProspective StudiesAgedTreatment OutcomeMagnetic Resonance ImagingDrug Therapy, CombinationProprotein Convertase 9

Stichwörter der Autor:innen

HR‐MRIPCSK9 inhibitorintracranial atherosclerotic stenosisischemic strokeplaque stability

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsPCSK9 InhibitorsevolocumabAntibodies, Monoclonal, HumanizedPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • Department of Neurology The First People's Hospital of Foshan Foshan Guangdong China.
  • Department of Radiology The First People's Hospital of Foshan Foshan Guangdong China.
  • Medical Imaging Center The First Affiliated Hospital of Jinan University Guangzhou Guangdong China.
  • Center for Biomedical Imaging Research, Department of Biomedical Engineering Tsinghua University School of Medicine Beijing China.
  • Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong SAR.
  • Neurointervention Service, Department of Radiology Royal Melbourne Hospital Melbourne Australia.

ORCID-Profile: Weiqi Zeng, Feng Zhou, Changzheng Shi, Xihai Zhao, Xinyi Leng, Bernard Yan, Zefeng Tan

Zitieren

APA

Zeng, W., Zhou, F., Zhao, H., Wang, Y., Chen, J., Lu, J., Zheng, D., Kuang, J., Yuan, D., Zhou, J., Shi, C., Zhao, X., Leng, X., Yan, B., & Tan, Z. (2025). Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035651

Vancouver

Zeng W, Zhou F, Zhao H, Wang Y, Chen J, Lu J, et al. Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.035651

BibTeX
@article{Zeng2025,
  author = {Zeng, Weiqi and Zhou, Feng and Zhao, Hai and Wang, Yukai and Chen, Jingjuan and Lu, Jiancong and Zheng, Dezhi and Kuang, Jingyun and Yuan, Dahua and Zhou, Jing and Shi, Changzheng and Zhao, Xihai and Leng, Xinyi and Yan, Bernard and Tan, Zefeng},
  title = {Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.035651}
}
Kostenlos starten →